Cargando…
Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Academy of Allergy, Asthma & Immunology
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211718/ https://www.ncbi.nlm.nih.gov/pubmed/32437739 http://dx.doi.org/10.1016/j.jaci.2020.05.002 |
| _version_ | 1783531501743243264 |
|---|---|
| author | Pontali, Emanuele Volpi, Stefano Antonucci, Giancarlo Castellaneta, Marco Buzzi, Davide Tricerri, Francesca Angelelli, Alessia Caorsi, Roberta Feasi, Marcello Calautti, Francesca Castagnola, Elio Rollandi, Gian Andrea Ravelli, Angelo Cassola, Giovanni Gattorno, Marco |
| author_facet | Pontali, Emanuele Volpi, Stefano Antonucci, Giancarlo Castellaneta, Marco Buzzi, Davide Tricerri, Francesca Angelelli, Alessia Caorsi, Roberta Feasi, Marcello Calautti, Francesca Castagnola, Elio Rollandi, Gian Andrea Ravelli, Angelo Cassola, Giovanni Gattorno, Marco |
| author_sort | Pontali, Emanuele |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7211718 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | American Academy of Allergy, Asthma & Immunology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72117182020-05-11 Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease Pontali, Emanuele Volpi, Stefano Antonucci, Giancarlo Castellaneta, Marco Buzzi, Davide Tricerri, Francesca Angelelli, Alessia Caorsi, Roberta Feasi, Marcello Calautti, Francesca Castagnola, Elio Rollandi, Gian Andrea Ravelli, Angelo Cassola, Giovanni Gattorno, Marco J Allergy Clin Immunol Letter to the Editor American Academy of Allergy, Asthma & Immunology 2020-07 2020-05-11 /pmc/articles/PMC7211718/ /pubmed/32437739 http://dx.doi.org/10.1016/j.jaci.2020.05.002 Text en © 2020 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Pontali, Emanuele Volpi, Stefano Antonucci, Giancarlo Castellaneta, Marco Buzzi, Davide Tricerri, Francesca Angelelli, Alessia Caorsi, Roberta Feasi, Marcello Calautti, Francesca Castagnola, Elio Rollandi, Gian Andrea Ravelli, Angelo Cassola, Giovanni Gattorno, Marco Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease |
| title | Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease |
| title_full | Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease |
| title_fullStr | Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease |
| title_full_unstemmed | Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease |
| title_short | Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease |
| title_sort | safety and efficacy of early high-dose iv anakinra in severe covid-19 lung disease |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211718/ https://www.ncbi.nlm.nih.gov/pubmed/32437739 http://dx.doi.org/10.1016/j.jaci.2020.05.002 |
| work_keys_str_mv | AT pontaliemanuele safetyandefficacyofearlyhighdoseivanakinrainseverecovid19lungdisease AT volpistefano safetyandefficacyofearlyhighdoseivanakinrainseverecovid19lungdisease AT antonuccigiancarlo safetyandefficacyofearlyhighdoseivanakinrainseverecovid19lungdisease AT castellanetamarco safetyandefficacyofearlyhighdoseivanakinrainseverecovid19lungdisease AT buzzidavide safetyandefficacyofearlyhighdoseivanakinrainseverecovid19lungdisease AT tricerrifrancesca safetyandefficacyofearlyhighdoseivanakinrainseverecovid19lungdisease AT angelellialessia safetyandefficacyofearlyhighdoseivanakinrainseverecovid19lungdisease AT caorsiroberta safetyandefficacyofearlyhighdoseivanakinrainseverecovid19lungdisease AT feasimarcello safetyandefficacyofearlyhighdoseivanakinrainseverecovid19lungdisease AT calauttifrancesca safetyandefficacyofearlyhighdoseivanakinrainseverecovid19lungdisease AT castagnolaelio safetyandefficacyofearlyhighdoseivanakinrainseverecovid19lungdisease AT rollandigianandrea safetyandefficacyofearlyhighdoseivanakinrainseverecovid19lungdisease AT ravelliangelo safetyandefficacyofearlyhighdoseivanakinrainseverecovid19lungdisease AT cassolagiovanni safetyandefficacyofearlyhighdoseivanakinrainseverecovid19lungdisease AT gattornomarco safetyandefficacyofearlyhighdoseivanakinrainseverecovid19lungdisease |